Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,19,1.06 [1.03-1.09],0.000287912894875715,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,19,1.08 [1.04-1.13],0.00040486097773087,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_BACT_INTEST_OTH,Inverse variance weighted,19,1.19 [1.07-1.33],0.00121125432240915,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,19,1.07 [1.03-1.12],0.00182258089444937,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,19,1.07 [1.03-1.12],0.00195709745122506,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,19,1.31 [1.09-1.56],0.0033661010742105,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,12,0.9 [0.83-0.97],0.00462672499668305,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,19,1.05 [1.01-1.09],0.00672429927709125,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,19,1.17 [1.04-1.32],0.0076524506307505,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,19,1.04 [1.01-1.08],0.0105853687674888,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,19,1.07 [1.01-1.13],0.0130448976708322,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,19,1.06 [1.01-1.1],0.0137158239007086,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,19,1.08 [1.02-1.15],0.0153005542231732,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,19,0.95 [0.91-0.99],0.0154219035243004,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,19,1.09 [1.02-1.17],0.0172891291224712,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,19,1.05 [1.01-1.1],0.0177028118585289,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,19,0.85 [0.74-0.97],0.0187911055762763,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Inverse variance weighted,12,1.08 [1.01-1.15],0.0205954821781292,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,19,1.08 [1.01-1.15],0.0229316460613606,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,19,1.18 [1.02-1.36],0.0254337321177539,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_FUNGAL_IMPL,Inverse variance weighted,12,1.2 [1.02-1.41],0.0273147361508561,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,19,1.73 [1.06-2.83],0.0286636725743062,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,19,1.07 [1.01-1.13],0.0294875645527605,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,19,0.95 [0.91-1],0.0352656663734829,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHINFLIV,Inverse variance weighted,19,1.21 [1-1.46],0.0445619607730439,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,12,0.85 [0.72-1],0.0457997723727135,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSPOR,Inverse variance weighted,12,1.29 [1-1.66],0.0468680778926997,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,19,1.04 [1-1.09],0.0506992460576775,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_EPLEPSY,Inverse variance weighted,19,1.08 [1-1.16],0.0540752968941183,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,19,1.1 [0.99-1.21],0.0646507881154634,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,19,1.08 [0.99-1.17],0.0675596465573936,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,19,1.07 [0.99-1.16],0.074906568546287,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_VIRAL_IMPL,Inverse variance weighted,12,1.12 [0.99-1.26],0.080163030484012,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,19,0.85 [0.72-1.02],0.0826920590738867,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Inverse variance weighted,11,1.05 [0.99-1.1],0.084939809059458,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,19,1.1 [0.99-1.23],0.0872435540504306,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,19,1.03 [1-1.07],0.0878314705618106,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,19,1.04 [0.99-1.09],0.0882039642552361,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,19,0.84 [0.68-1.03],0.0904749600439969,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,19,0.94 [0.88-1.01],0.0904938770777767,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,19,1.04 [0.99-1.09],0.0963783417408391,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GIDISEASES,Inverse variance weighted,12,1.02 [1-1.05],0.0965290983500618,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,19,1.07 [0.99-1.16],0.100205100780613,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_MUSCULOSKELETAL,Inverse variance weighted,12,1.02 [1-1.06],0.10183556514912,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,19,1.06 [0.99-1.15],0.101913361527529,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,19,1.08 [0.98-1.18],0.106644367027502,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,19,0.86 [0.72-1.03],0.108292512567539,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,ULCERNAS,Inverse variance weighted,19,1.1 [0.98-1.24],0.111862389857341,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,19,1.14 [0.97-1.34],0.113004970901922,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,19,1.06 [0.99-1.13],0.113134960207303,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_NEURO,Inverse variance weighted,12,1.03 [0.99-1.07],0.12561435854989,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2OPTH,Inverse variance weighted,19,0.9 [0.78-1.03],0.130185012584926,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,19,1.49 [0.89-2.51],0.132043803350279,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,Inverse variance weighted,12,1.12 [0.97-1.29],0.132092850365053,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,19,0.92 [0.83-1.03],0.13969460426552,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,19,0.93 [0.84-1.03],0.139868049028193,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,19,0.97 [0.94-1.01],0.143873277610448,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LIMBPAIN,Inverse variance weighted,19,1.04 [0.99-1.1],0.150691634333669,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,19,1.16 [0.94-1.44],0.158784180972301,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,19,1.1 [0.96-1.25],0.169497302584806,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,19,1.04 [0.98-1.09],0.170374806251972,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,KRA_PSY_MOOD_EXMORE,Inverse variance weighted,12,1.04 [0.98-1.1],0.172122461587769,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,19,1.03 [0.99-1.08],0.172661556037837,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_VEINSOTH,Inverse variance weighted,19,0.94 [0.87-1.03],0.178463554064447,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROMBDVTLOW,Inverse variance weighted,19,0.94 [0.87-1.03],0.183396086142225,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,19,0.84 [0.66-1.08],0.183467966043778,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,19,0.96 [0.9-1.02],0.184148104221853,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Inverse variance weighted,12,1.04 [0.98-1.09],0.192431584747092,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,19,0.9 [0.78-1.05],0.194143161198342,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,19,1.07 [0.96-1.19],0.201766555371176,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,19,0.96 [0.91-1.02],0.207860239056242,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,19,1.07 [0.96-1.18],0.209619018251462,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,19,1.17 [0.92-1.49],0.210129760398857,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROM,Inverse variance weighted,19,0.93 [0.84-1.04],0.210510517329967,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,19,0.96 [0.91-1.02],0.211859398073447,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,19,1.12 [0.94-1.33],0.21341577902295,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITYNAS,Inverse variance weighted,19,1.05 [0.97-1.13],0.229392631074058,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,19,1.08 [0.95-1.23],0.232222186492407,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,19,0.96 [0.89-1.03],0.23350555373222,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,19,0.95 [0.87-1.04],0.234909382724737,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,19,1.1 [0.94-1.28],0.235098337080121,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,19,1.05 [0.97-1.14],0.245010474887827,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,19,0.95 [0.88-1.03],0.253798431093717,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,19,1.03 [0.98-1.1],0.257709300296538,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ITP,Inverse variance weighted,19,0.85 [0.64-1.13],0.260683989450389,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITY,Inverse variance weighted,19,1.04 [0.97-1.12],0.267145620731156,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_POLY,Inverse variance weighted,19,1.06 [0.95-1.18],0.274379439193256,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,19,1.14 [0.9-1.44],0.28904846943242,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,19,1.02 [0.98-1.06],0.290575659874022,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,19,0.87 [0.67-1.13],0.291660032082168,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,19,1.05 [0.96-1.16],0.292790651133914,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,19,1.09 [0.93-1.27],0.29502055122964,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Inverse variance weighted,12,1.02 [0.98-1.05],0.297729658392532,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,19,0.89 [0.72-1.11],0.303387391592742,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,12,0.92 [0.79-1.08],0.312991153669583,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,19,1.02 [0.98-1.07],0.314146337218073,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,19,1.21 [0.84-1.74],0.315184426331731,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,19,1.12 [0.9-1.39],0.317943316849072,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Inverse variance weighted,12,1.02 [0.98-1.07],0.318982309870446,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,19,1.03 [0.97-1.11],0.32234652015142,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,19,1.1 [0.91-1.32],0.326989796494914,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,19,0.98 [0.93-1.02],0.337113496491026,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,19,0.97 [0.92-1.03],0.340203676525435,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,PHLEB_VENAE_ILIAC_EXTER,Inverse variance weighted,12,0.91 [0.76-1.1],0.340663324762224,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,19,1.09 [0.91-1.32],0.353878379709837,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,19,1.02 [0.98-1.06],0.362898316561746,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,19,0.94 [0.83-1.07],0.371554069716721,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,19,1.02 [0.97-1.07],0.383765502657309,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GIBLEEDING,Inverse variance weighted,12,1.03 [0.96-1.1],0.398795452625334,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,19,0.98 [0.93-1.03],0.401009082052624,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Inverse variance weighted,12,0.92 [0.75-1.12],0.413114490231003,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,19,1.07 [0.91-1.25],0.415078014052698,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,19,1.02 [0.97-1.07],0.420350618410864,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,12,1.02 [0.98-1.06],0.42650614056165,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,19,1.05 [0.93-1.2],0.431371437920842,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,19,1.08 [0.9-1.29],0.431983608232829,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,19,1.03 [0.95-1.13],0.434380027066751,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,19,1.02 [0.97-1.08],0.438072199967649,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter II Neoplasms,C3_BILIARY_GALLBLADDER_EXALLC,Inverse variance weighted,19,1.1 [0.86-1.41],0.441472524257074,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GULC,Inverse variance weighted,19,1.04 [0.94-1.16],0.444718916464081,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,19,1.05 [0.93-1.18],0.446696790589204,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,19,1.06 [0.91-1.25],0.450392368210151,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,19,0.96 [0.86-1.07],0.464300753706216,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,19,0.93 [0.78-1.12],0.464711179982627,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,19,0.98 [0.94-1.03],0.465973301848093,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,19,0.97 [0.89-1.05],0.484553789010016,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,PNEUMOBACTKNOWN,Inverse variance weighted,12,1.07 [0.88-1.31],0.502855508862093,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,19,1.05 [0.91-1.21],0.51152302311707,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,19,0.96 [0.86-1.08],0.512265330709084,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_STR_SAH,Inverse variance weighted,12,1.04 [0.93-1.16],0.513459599173742,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,19,1.02 [0.97-1.07],0.517619559066776,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,19,1.04 [0.92-1.17],0.539303350438852,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHRITISNAS,Inverse variance weighted,12,0.98 [0.93-1.04],0.541105048775156,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Inverse variance weighted,12,0.98 [0.92-1.05],0.543764030727057,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,19,1.02 [0.95-1.11],0.545297469775555,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,19,0.95 [0.8-1.13],0.551614367473763,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Inverse variance weighted,12,1.02 [0.95-1.11],0.559995321626839,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SLE,Inverse variance weighted,12,1.19 [0.65-2.17],0.566256950556431,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,19,1.02 [0.95-1.1],0.566878200554832,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,19,0.98 [0.9-1.06],0.571483044780139,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Inverse variance weighted,12,1.05 [0.89-1.24],0.576146468161873,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,19,1.1 [0.79-1.52],0.577789122734134,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_SKIN_SUBCUTAN,Inverse variance weighted,12,1.01 [0.96-1.07],0.589717871125646,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,19,1.03 [0.92-1.16],0.600234207715522,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,19,0.99 [0.95-1.03],0.605228387013265,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,12,1.04 [0.9-1.21],0.6112096120449,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,19,1.18 [0.62-2.24],0.61580809570008,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,19,1.03 [0.92-1.15],0.623230989298077,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,19,1.02 [0.94-1.11],0.625120368291802,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,19,0.96 [0.8-1.14],0.625965252301079,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,12,1.03 [0.9-1.19],0.627358396644513,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,12,1.02 [0.93-1.12],0.627635993495041,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,19,1.04 [0.88-1.23],0.633085532857468,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Inverse variance weighted,12,1.02 [0.95-1.1],0.63562363751937,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,19,1.02 [0.95-1.08],0.643310570661965,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,19,0.98 [0.89-1.07],0.643708233653977,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_LUPUS,Inverse variance weighted,19,1.07 [0.79-1.47],0.650631511224182,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,19,0.98 [0.88-1.08],0.651502337653738,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,19,0.97 [0.84-1.12],0.65499370419983,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_OTHNEU,Inverse variance weighted,19,1.01 [0.96-1.08],0.660995782241716,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,19,1.01 [0.97-1.05],0.67365633077984,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PULMOEDEMA,Inverse variance weighted,19,1.08 [0.75-1.55],0.682721729164523,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,19,1.01 [0.96-1.06],0.703476731840129,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOMYELITIS,Inverse variance weighted,19,1.05 [0.81-1.36],0.704456209594246,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,19,0.96 [0.77-1.19],0.704967687968302,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,19,1.04 [0.82-1.33],0.729160388499151,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,19,0.99 [0.95-1.04],0.730880735051487,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_PERITON,Inverse variance weighted,19,1.03 [0.85-1.26],0.731655183361,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,19,0.97 [0.82-1.15],0.732754839563521,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,19,0.96 [0.78-1.19],0.736566014414756,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Inverse variance weighted,12,1.01 [0.94-1.09],0.736777589205412,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,19,0.99 [0.95-1.04],0.739179052739698,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,19,0.96 [0.74-1.24],0.739943318104714,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHCONN,Inverse variance weighted,12,0.98 [0.86-1.11],0.744069836402285,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,19,0.99 [0.93-1.06],0.754071948419055,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,19,1.12 [0.53-2.38],0.759128416521245,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,19,1.01 [0.97-1.05],0.76631155411222,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_RECURANDPERHEAMATUR,Inverse variance weighted,19,0.92 [0.54-1.58],0.771288208768667,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,IBD_BACT_INTEST_INFECTIONS,Inverse variance weighted,12,0.98 [0.85-1.13],0.773503197833312,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,19,1.03 [0.84-1.26],0.773537714470094,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,19,0.98 [0.88-1.1],0.77466347480653,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,19,1.04 [0.8-1.36],0.777920533733223,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,19,1 [0.97-1.04],0.778296461341088,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,12,1.01 [0.95-1.06],0.782238039230801,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,19,0.99 [0.9-1.08],0.783351115729454,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,19,0.98 [0.85-1.13],0.793815099121622,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,19,0.97 [0.79-1.19],0.798183269671005,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,19,0.95 [0.64-1.42],0.807433482810251,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,19,1.02 [0.88-1.17],0.808832014957548,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,19,0.97 [0.76-1.25],0.82180890184454,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,19,1.02 [0.81-1.3],0.842023603326317,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,19,1.02 [0.85-1.22],0.844443756079222,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,19,0.99 [0.87-1.12],0.848864061702712,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,19,0.98 [0.76-1.26],0.85396577351706,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Inverse variance weighted,12,1 [0.96-1.04],0.855956422870213,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,19,0.98 [0.8-1.21],0.86079428644021,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,19,0.99 [0.94-1.06],0.867563058063123,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,19,0.99 [0.86-1.13],0.876253964803216,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERAPLASTICANAEMIA,Inverse variance weighted,19,0.96 [0.54-1.69],0.882746556017774,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,19,1.02 [0.78-1.34],0.889297665795907,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Inverse variance weighted,19,1.01 [0.85-1.21],0.90608207665453,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,19,1.01 [0.84-1.21],0.921673268360644,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDISOES,Inverse variance weighted,19,0.99 [0.86-1.15],0.931693887920105,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,19,1 [0.88-1.12],0.940599009453027,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Inverse variance weighted,12,1 [0.93-1.07],0.940696981894492,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,19,1 [0.91-1.09],0.951246157425855,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,19,0.99 [0.75-1.31],0.958168604472707,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_MALEGEN,Inverse variance weighted,19,1 [0.96-1.05],0.974151059321789,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,19,1 [0.92-1.08],0.998155280066969,cis
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,20,1.11 [1.03-1.2],0.00510008368498299,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITYNAS,Inverse variance weighted,20,1.19 [1.05-1.36],0.0077358063814905,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,20,1.09 [1.02-1.16],0.00884382451495878,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,20,0.85 [0.74-0.97],0.0194612244714324,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,20,1.06 [1-1.13],0.0358450695008546,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,20,1.25 [1.01-1.53],0.0359423932814277,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_OBESITY,Inverse variance weighted,20,1.13 [1-1.27],0.0424182198284601,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,20,0.43 [0.18-1.01],0.0533692852111573,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,20,1.12 [1-1.25],0.057241700019641,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,20,1.08 [0.99-1.16],0.0705162946587839,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,20,0.94 [0.88-1.01],0.0831345159633503,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,20,1.26 [0.97-1.65],0.0835602743218284,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,20,0.92 [0.83-1.01],0.088565307501816,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,20,1.25 [0.96-1.63],0.0918389716271885,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,20,1.13 [0.98-1.3],0.0946868588346496,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,20,0.85 [0.71-1.03],0.0997618496523913,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,20,0.94 [0.87-1.01],0.103935311710025,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_PERITON,Inverse variance weighted,20,0.81 [0.63-1.05],0.105949784791958,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,20,0.86 [0.71-1.04],0.113848386117937,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,20,0.92 [0.83-1.02],0.125736233289296,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,20,0.93 [0.84-1.02],0.132325684528414,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,20,1.06 [0.98-1.15],0.132906881021444,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,20,1.2 [0.94-1.54],0.140054623871663,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,20,1.08 [0.97-1.21],0.151517638804112,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,20,1.04 [0.99-1.09],0.164301952195931,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,20,1.44 [0.85-2.42],0.171601594892531,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,20,0.94 [0.85-1.03],0.173507488158689,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_TUBULOINTNEPHRNAS,Inverse variance weighted,20,1.22 [0.91-1.64],0.177934782434193,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,20,1.06 [0.97-1.15],0.179085515310227,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,20,1.33 [0.87-2.03],0.180992162867599,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,20,0.97 [0.92-1.02],0.183070498318603,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,20,1.18 [0.92-1.52],0.200588463559206,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANXIETY_EXMORE,Inverse variance weighted,20,0.95 [0.88-1.03],0.202389218790461,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,20,1.24 [0.89-1.73],0.206979964684279,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,20,1.1 [0.95-1.29],0.212911519168094,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,20,1.07 [0.96-1.2],0.213158429345577,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,20,1.1 [0.94-1.28],0.221290985540406,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,20,0.86 [0.68-1.09],0.222901745046857,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,20,0.81 [0.57-1.15],0.233752995875215,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,20,0.73 [0.43-1.24],0.240160792597879,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LIMBPAIN,Inverse variance weighted,20,0.93 [0.83-1.05],0.240683398961985,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,20,1.3 [0.83-2.02],0.247521506583438,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_POLY,Inverse variance weighted,20,1.11 [0.93-1.32],0.253437694628461,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,20,1.11 [0.93-1.32],0.255437901652006,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,20,0.88 [0.71-1.1],0.27521524938784,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,20,1.07 [0.95-1.2],0.281513254623461,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHINFLIV,Inverse variance weighted,20,0.84 [0.62-1.15],0.283105080830576,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,20,0.95 [0.86-1.05],0.283412740188503,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,20,1.8 [0.61-5.34],0.289260192785556,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Inverse variance weighted,20,0.85 [0.62-1.16],0.295197034991984,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2OPTH,Inverse variance weighted,20,1.14 [0.89-1.47],0.302347029726057,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_GULC,Inverse variance weighted,20,1.1 [0.91-1.34],0.312795550006017,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,20,0.97 [0.93-1.03],0.315573757760428,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,20,1.09 [0.92-1.29],0.325625970442293,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_KIDUROTH,Inverse variance weighted,20,0.89 [0.71-1.12],0.327467512972588,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,20,0.97 [0.92-1.03],0.332273195958883,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_RECURANDPERHEAMATUR,Inverse variance weighted,20,0.56 [0.17-1.84],0.336434517364258,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_PERITONITIS,Inverse variance weighted,20,0.85 [0.6-1.19],0.337180543739443,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,20,1.09 [0.91-1.32],0.349072602188111,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,20,0.92 [0.77-1.1],0.357936276910276,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_BACT_INTEST_OTH,Inverse variance weighted,20,0.92 [0.77-1.1],0.372948505013569,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,20,0.92 [0.77-1.1],0.373424504851888,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_LUPUS,Inverse variance weighted,20,0.78 [0.45-1.36],0.382701028785431,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,20,0.77 [0.42-1.41],0.394663670611004,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_EPLEPSY,Inverse variance weighted,20,0.95 [0.83-1.07],0.398136663531457,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERAPLASTICANAEMIA,Inverse variance weighted,20,0.71 [0.32-1.57],0.40222528121746,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,20,1.09 [0.89-1.34],0.403062133834071,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,20,1.2 [0.78-1.86],0.403794107956736,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,20,1.06 [0.92-1.22],0.404667424100219,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,20,0.86 [0.61-1.22],0.405622071195415,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,20,1.04 [0.94-1.15],0.406263100337901,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,20,1.42 [0.62-3.25],0.408155461104329,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,20,1.11 [0.87-1.41],0.408675716036494,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,20,1.03 [0.96-1.1],0.416627510892393,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,20,0.83 [0.54-1.3],0.419178282562298,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,20,0.98 [0.92-1.04],0.421750294305456,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOMYELITIS,Inverse variance weighted,20,0.85 [0.56-1.28],0.425601991722629,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,20,1.11 [0.85-1.45],0.430898092604478,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUENAS,Inverse variance weighted,20,0.87 [0.61-1.24],0.43595476955641,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PLASMAPROT,Inverse variance weighted,20,0.67 [0.24-1.85],0.439215202361124,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,20,1.04 [0.94-1.15],0.446935015479466,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,20,0.97 [0.88-1.06],0.472181508465323,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Inverse variance weighted,20,0.88 [0.61-1.26],0.4737525197666,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,20,0.86 [0.57-1.32],0.492028332438439,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,20,0.97 [0.88-1.07],0.509777380029313,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,20,0.93 [0.75-1.15],0.511168847789301,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,20,1.04 [0.93-1.15],0.520969784083338,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,20,0.91 [0.69-1.21],0.528410888536865,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,20,1.22 [0.65-2.28],0.531609073921434,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,20,1.03 [0.95-1.11],0.535019767121903,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,20,0.91 [0.66-1.24],0.545346681949908,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,20,1.1 [0.81-1.5],0.547933243992212,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,20,0.9 [0.62-1.29],0.551939799559027,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,20,0.98 [0.9-1.06],0.557945612254202,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,20,0.96 [0.84-1.1],0.560062635653379,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOSIS,Inverse variance weighted,20,0.97 [0.88-1.07],0.575696100709826,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,20,1.1 [0.78-1.55],0.584209325162832,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,20,0.91 [0.64-1.3],0.611312107715809,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROM,Inverse variance weighted,20,0.95 [0.8-1.15],0.619330200686873,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,20,1.05 [0.87-1.25],0.628189084587932,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,20,1.08 [0.79-1.48],0.630244574457594,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,20,0.96 [0.83-1.12],0.630509848129649,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,20,1.02 [0.93-1.13],0.636087682134488,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,20,0.88 [0.53-1.47],0.638053189154897,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PULMOEDEMA,Inverse variance weighted,20,0.86 [0.47-1.6],0.63958333005585,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,20,1.05 [0.85-1.3],0.644484222667054,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,20,0.91 [0.59-1.38],0.645604689119721,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,20,1.03 [0.92-1.14],0.65247280149704,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,20,1.04 [0.87-1.24],0.661321644804022,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,20,1.02 [0.93-1.12],0.664367674180667,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,20,0.98 [0.91-1.06],0.667523480154264,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,20,1.03 [0.9-1.18],0.670446604338119,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,20,0.93 [0.66-1.3],0.673431384524994,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,20,1.02 [0.93-1.12],0.67353285146293,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,20,0.94 [0.69-1.28],0.676831188788091,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_VIRAL_OTHER_INTEST_INFECTIONS,Inverse variance weighted,20,0.96 [0.81-1.15],0.679148914930674,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,20,0.96 [0.78-1.17],0.686989208705684,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,20,1.02 [0.92-1.13],0.688621547411905,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,20,0.94 [0.69-1.28],0.691660891944183,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,20,0.97 [0.85-1.12],0.694690468959291,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,20,0.97 [0.82-1.14],0.69656076589154,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,20,1.04 [0.85-1.28],0.700314908369448,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,20,0.95 [0.75-1.22],0.701671036887063,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_VEINSOTH,Inverse variance weighted,20,0.97 [0.84-1.13],0.70236058485004,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,20,1.04 [0.83-1.3],0.715010870605854,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,20,0.98 [0.9-1.08],0.716976477140129,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,ULCERNAS,Inverse variance weighted,20,0.96 [0.79-1.18],0.722075906367821,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,20,1.03 [0.86-1.24],0.722925561775992,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,JOINTPAIN,Inverse variance weighted,20,0.98 [0.88-1.09],0.724954733881005,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,C_DIFFICILE_ENTEROCOLITIS,Inverse variance weighted,20,0.96 [0.75-1.22],0.733516394838623,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,20,1.04 [0.83-1.31],0.741052333672405,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,20,0.98 [0.85-1.13],0.742024570088088,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,20,0.98 [0.86-1.11],0.743630642143152,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,20,0.96 [0.75-1.23],0.750283339377471,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS,Inverse variance weighted,20,0.99 [0.9-1.08],0.750299443414197,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ITP,Inverse variance weighted,20,1.09 [0.64-1.87],0.756174769007588,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDISOES,Inverse variance weighted,20,1.04 [0.81-1.33],0.756538094517172,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,20,0.96 [0.71-1.28],0.771326616172522,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,20,1.06 [0.71-1.58],0.773163137998971,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,20,0.99 [0.9-1.08],0.77580913662596,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,20,1.04 [0.77-1.41],0.786769703962749,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_PHLETHROMBDVTLOW,Inverse variance weighted,20,0.97 [0.8-1.19],0.793473429269159,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,20,1.02 [0.88-1.18],0.797280000704835,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,20,1.03 [0.8-1.33],0.797482401014491,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,20,1.04 [0.76-1.43],0.797908384612948,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,20,0.99 [0.91-1.07],0.805764318944595,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,20,1.03 [0.79-1.34],0.818341877820777,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,20,1.02 [0.88-1.18],0.818953620141985,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,20,0.99 [0.88-1.1],0.821159413980968,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,20,1.01 [0.95-1.06],0.835604909565692,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_INCLAVO,Inverse variance weighted,20,0.99 [0.91-1.08],0.836893646817966,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,20,1.05 [0.62-1.78],0.842766256654951,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,20,1.01 [0.94-1.08],0.845737258228198,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,20,1.01 [0.88-1.17],0.846874478215494,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,20,0.98 [0.84-1.16],0.850515537783388,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,20,0.98 [0.75-1.27],0.851548564698806,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,20,0.99 [0.91-1.09],0.866259896020496,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Inverse variance weighted,20,0.98 [0.67-1.41],0.896496536603964,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIV Diseases of the genitourinary system,N14_MALEGEN,Inverse variance weighted,20,1.01 [0.92-1.09],0.897573133168413,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter VI Diseases of the nervous system,G6_OTHNEU,Inverse variance weighted,20,1 [0.92-1.09],0.912861965614684,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,20,0.99 [0.81-1.21],0.924053848608563,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,20,1.01 [0.78-1.31],0.933917761270969,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,20,1 [0.91-1.1],0.936897661747924,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter II Neoplasms,C3_BILIARY_GALLBLADDER_EXALLC,Inverse variance weighted,20,0.98 [0.62-1.54],0.93828123954161,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROSIS_OTH,Inverse variance weighted,20,1 [0.86-1.15],0.948033572842635,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,20,0.99 [0.77-1.29],0.961025407444887,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,20,1.01 [0.82-1.24],0.96159524044883,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,20,1.01 [0.65-1.56],0.968950905238081,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,20,1 [0.74-1.35],0.977319703395102,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SPONDYLOPATHY,Inverse variance weighted,20,1 [0.93-1.08],0.988821484806201,trans
NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,20,1 [0.79-1.26],0.996950058944553,trans
